Update on Mpox Management: Epidemiology, Vaccines and Therapeutics, and Regulatory Changes

2024/11/05 by Youssef Rizk, Giuseppe Lippi, Brandon M. Henry +3 · 9 citations
Immunology and Microbiology · Biochemistry, Genetics and Molecular Biology · #Poxvirus research and outbreaks #Bacillus and Francisella bacterial research #Rabies epidemiology and control

paper · doi:10.1007/s40265-024-02117-1

Citations

• Vaccine effectiveness of 3rd generation mpox vaccines against mpox and disease severity: A systematic review and meta-analysis

Cited by

• Development and Validation of LAMP Assays for Distinguishing MPXV Clades with Fluorescent and Colorimetric Readouts. [europepmc]
• Monkeypox virus H3L protein as the target antigen for developing neutralizing antibody and serological assay. [europepmc]
• Mpox unveiled: Global epidemiology, treatment advances, and prevention strategies. [europepmc]
• Accelerating the approval of mpox vaccines based on lessons learnt from COVID-19 vaccines through the lens of regulatory science. [europepmc]
• Evolving Threats: Adaptive Mechanisms of Monkeypox Virus (MPXV) in the 2022 Global Outbreak and Their Implications for Vaccine Strategies. [europepmc]
• Current infectious disease management challenges in inborn errors of immunity. [europepmc]
• CircRNA based bi-antigen vaccines against mpox virus induce potent and durable cross-protection in mice. [europepmc]
• Insights into Monkeypox Virus: Host Immunity, Viral Immune Evasion, Recent Advances in Vaccines, Therapeutic Development, and Future Perspectives [europepmc]
• Antiviral potential of black tea and blueberry extracts against monkeypox virus by targeting orthopoxvirus surface proteins [europepmc]